Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma
Clinical trial NCT01970527 · TERMINATED
Trial details
- NCT number
- NCT01970527
- Sponsor
- University of Washington
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2018-11-03
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.